Here’s what you need to know:
1. The market reached $39.48 billion in 2015.
2. The market is expected to grow with a CAGR of 5.7 percent, reaching $58.2 billion by 2022.
3. Key players in the market include North Chicago, Ill.-based AbbVie; New Brunswick, N.J.-based Johnson & Johnson and New York City-based Pfizer.
4. This recent market growth is attributed to increasing pain disorders, technological developments and growing geriatric population.
5. One of the barriers to continued market growth is competition between companies.
More articles on anesthesia:
22 things to know about anesthesia
NorthStar Anesthesia acquires Square Waveform Anesthesiology
Plexus Technology Group, HEYER Medical AG partner for integrated anesthesia EMR: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.